Table 1.
Participant characteristics (n = 133)
| PD (n = 97) | HC (n = 36) | p-values | |
|---|---|---|---|
| Age (yrs) | 66.86 (10.03) | 69.64 (6.57) | 0.169 |
| Sex (f/m) | 28/69 | 16/20 | 0.136 |
| MoCA | 25.31 (2.99) | 27.11(2.61) | < 0.001* |
| Mini-BESTest | 21.91 (4.84) | 25.33(2.35) | < 0.001* |
| DD (yrs) | 9.86 (6.8) | – | – |
|
H&Y (1/2/3/4) |
2 (1–4) (1/61/29/6) |
– | – |
| MDS-UPDRS III | 34.4 (14.16) | – | – |
| NFOG-Q# (n = 64) | 16.05 (5.73) | – | – |
| Age (yrs) | 66.86 (10.03) | 69.64 (6.57) | 0.169 |
| Sex (f/m) | 28/69 | 16/20 | 0.136 |
| MoCA | 25.31 (2.99) | 27.11(2.61) | < 0.001* |
| Mini-BESTest | 21.91 (4.84) | 25.33(2.35) | < 0.001* |
| DD (yrs) | 9.86 (6.8) | – | – |
|
H&Y (1/2/3/4) |
2 (1–4) (1/61/29/6) |
– | – |
| MDS-UPDRS III | 34.4 (14.16) | – | – |
| NFOG-Q# (n = 64) | 16.05 (5.73) | – | – |
MoCA Montreal Cognitive Assessment, DD disease duration, H&Y Hoehn and Yahr stage, MDS-UPDRS III movement disorder society-unified Parkinson’s disease rating scale part III; NFOG-Q new freezing of gait questionnaire; Data on disease duration, MDS-UPDRS-III and MoCA are for n = 96; # for n = 64 (only individuals with FOG)
*Statistically significant (p < 0.05). Presented are mean (sd)